Investigating how reactive astrocytes affect tau protein in Alzheimer's disease
The Role of Reactive Astrocytes in the Propagation and Clearance of Tau in Alzheimer's Disease
This study is looking at how certain brain cells called astrocytes might help get rid of harmful tau proteins linked to Alzheimer's disease, which could lead to new treatments to protect brain cells and improve care for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11134812 on NIH RePORTER |
What this research studies
This research explores the role of reactive astrocytes in the brain and how they interact with tau proteins associated with Alzheimer's disease. By studying a specific mouse model, the researchers aim to understand whether the upregulation of a protein called GFAP in astrocytes helps to clear harmful tau proteins and protect neurons from damage. The approach involves examining the effects of astrocytes on tau propagation and clearance, which could lead to new insights into Alzheimer's disease mechanisms. Patients may benefit from findings that could inform future therapies targeting tau pathology.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to tau pathology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that enhance the brain's ability to clear toxic tau proteins, potentially slowing the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding the role of astrocytes in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Serrano-Pozo, Alberto — Massachusetts General Hospital
- Study coordinator: Serrano-Pozo, Alberto
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.